financetom
STEL
financetom
/
Financials
/
STEL
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Stellar Bancorp, Inc.STEL
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Stellar Bancorp, Inc. operates as the bank holding company that provides a range of commercial banking services primarily to small and medium-sized businesses, professionals, and individual customers.

It accepts deposit products, including checking accounts, commercial accounts, money market accounts, savings accounts, and other time deposits; and certificates of deposit.

The company's loan portfolio comprises commercial and industrial loans; commercial real estate loans, including multi-family residential loans; commercial real estate construction and land development loans; residential real estate loans comprising 1-4 family residential mortgage loans, such as home equity and home improvement loans, and home equity lines of credit; residential construction loans; and consumer and other loans.

In addition, it offers automated teller machine services, drive-through services, and depository facilities; mobile banking services; and telephone, mail, and Internet banking services.

Further, the company provides safe deposit boxes, debit cards, cash management and wire transfer services, night depository services, direct deposits, cashier's checks, and letters of credit.

Stellar Bancorp, Inc. was founded in 2007 and is headquartered in Houston, Texas.

Latest News >
Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial
Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial
Dec 31, 2024
02:15 PM EST, 12/31/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) ADC Therapeutics ( ADCT ) gained as much as 4.2% in intraday trading Tuesday after the company said it had completed patient enrollment in its phase 3 confirmatory trial of Zynlonta in combination with rituximab in patients with relapsed or refractory diffuse...
Legacy Housing Insider Sold Shares Worth $425,099, According to a Recent SEC Filing
Legacy Housing Insider Sold Shares Worth $425,099, According to a Recent SEC Filing
Dec 31, 2024
02:11 PM EST, 12/31/2024 (MT Newswires) -- Curtis Drew Hodgson, 10% Owner, Director, on December 30, 2024, sold 17,300 shares in Legacy Housing ( LEGH ) for $425,099. Following the Form 4 filing with the SEC, Hodgson has control over a total of 4,173,778 shares of the company, with 404,722 shares held directly and 3,769,056 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1436208/000110465924132810/xslF345X05/tm2432358-1_4seq1.xml...
Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing
Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing
Dec 31, 2024
02:11 PM EST, 12/31/2024 (MT Newswires) -- Emil D Kakkis, Director, President & CEO, on December 30, 2024, sold 11,727 shares in Ultragenyx Pharmaceutical ( RARE ) for $495,231. Following the Form 4 filing with the SEC, Kakkis has control over a total of 2,748,590 shares of the company, with 564,605 shares held directly and 2,183,985 controlled indirectly. SEC Filing:...
Boeing on track to be 2024's biggest loser in Dow Jones Index
Boeing on track to be 2024's biggest loser in Dow Jones Index
Dec 31, 2024
(Reuters) - U.S. planemaker Boeing ( BA ) is on track to be the biggest loser of 2024 in the Dow Jones Index, tumbling 32% as it bounced from one crisis to another.  Rival Airbus rose more than 11% for the year, and the benchmark S&P 500 gained more than 23% during 2024.  Boeing's ( BA ) shares opened the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved